Managing Creativity and Discovery in Pharma and University, with an Example from Motor Neuron Disease

Michael Spedding has worked at all levels within the pharmaceutical industry while maintaining a strong academic output (h-index 81). He has built two research centres and taken 12 drugs into clinical trials across multiple indications. His company now has a drug in Phase II for motor neuron disease, using a highly original approach and operating with no debt. This webinar will explore how this has been achieved while maintaining a balanced life, highlighting distinct philosophies, management and creativity styles, evolving scientific approaches, and offering potential hope for diseases often considered ‘impossible’.